National / Science & Health Aug 8, 2017
AstraZeneca seeks Japan's first approval for hereditary cancer drug in relapsed sufferers
by Alex K.T. Martin
Olaparib, already approved in the United States and the European Union, acts against cancers in people with hereditary mutations in genes associated with breast and ovarian cancer.
